2,832
Views
9
CrossRef citations to date
0
Altmetric
Research Article

HPLC-UV/HRMS methods for the unambiguous detection of adulterations of Ginkgo biloba leaves with Sophora japonica fruits on an extract level

, , &
Pages 436-441 | Received 07 Oct 2020, Accepted 25 Mar 2021, Published online: 22 Apr 2021

References

  • Avula B, Sagi S, Gafner S, Upton R, Wang YH, Wang M, Khan IA. 2015. Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry. Anal Bioanal Chem. 407(25):7733–7746.
  • Basta D. 2017. Schwindel im Alter und vaskulär bedingter Schwindel [Pres by vertigo and vascular vertigo]. Die Medizinische Welt. 68:46–52.
  • Booker A, Frommenwiler D, Reich E, Horsfield S, Heinrich M. 2016. Adulteration and poor quality of Ginkgo biloba supplements. J Herb Med. 6(2):79–87.
  • Chandra A, Li Y, Rana J, Persons K, Hyun C, Shen S, Mulder T. 2011. Qualitative categorization of supplement grade Ginkgo biloba leaf extracts for authenticity. J Funct Foods. 3(2):107–114.
  • Chang L, Ren Y, Cao L, Sun Y, Sun Q, Sheng N, Yuan L, Zhi X, Zhang L. 2012. Simultaneous determination and pharmacokinetic study of six flavonoids from Fructus Sophorae extract in rat plasma by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 904:59–64.
  • China Food and Drug Administration. 2015. Announcement of the China Food and Drug Administration on the supplemental test method for Ginkgo leaves soft capsule and so on: Attachment 6. The supplemental test method for Sophoricoside in the Ginkgo extracts, Ginkgo leaves tablets and capsules. No. 142. Chinese.
  • Chinese Medicine Division, Department of Health. 2012. Hong Kong Chinese Materia Medica Standards. Vol. 5. Hong Kong (China): Chinese Medicine Division, Department of Health; p. 379–389.
  • Committee on Herbal Medicinal Products, European Medicines Agency. 2015. European Union herbal monograph on Ginkgo biloba L., folium. Amsterdam (The Netherlands): EMA; [accessed 2021 Feb 01]. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-ginkgo-biloba-l-folium_en.pdf.
  • European Directorate for the Quality of Medicines and Healthcare, Council of Europe. 2019. European Pharmacopeia. 10th ed. Supplement 10.0. Stuttgart (Germany): Deutscher Apotheker Verlag; p. 1451–1453.
  • Frommenwiler DA, Booker A, Vila R, Heinrich M, Reich E, Cañigueral S. 2019. Comprehensive HPTLC fingerprinting as a tool for a simplified analysis of purity of ginkgo products. J Ethnopharmacol. DOI:10.1016/j.jep.2019.112084.
  • Gafner S. 2018. Adulteration of Ginkgo biloba leaf extract. Botanical Adulterants Bulletin. [accessed 2021 Feb 01]:[8 p.]. http://cms.herbalgram.org/BAP/BAB/GinkgoBulletin.html.
  • Gauthier S, Schlaefke S. 2014. Efficacy and tolerability of Ginkgo biloba extract EGb 761© in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clin Interv Aging. 9:2065–2077.
  • Harnly JM, Luthria D, Chen P. 2012. Detection of adulterated Ginkgo biloba supplements using chromatographic and spectral fingerprints. J AOAC Int. 95(6):1579–1587.
  • He X, Bai Y, Zhao Z, Wang X, Fang J, Huang L, Zeng M, Zhang Q, Zhang Y, Zheng X. 2016. Local and traditional uses, phytochemistry, and pharmacology of Sophora japonica L.: a review. J Ethnopharmacol. 187:160–182.
  • Horsch S, Walther C. 2004. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)-a review based on randomized, controlled studies. Int J Clin Pharmacol Ther. 42(2):63–72.
  • Liu XG, Yang H, Cheng XL, Liu L, Qin Y, Wang Q, Qi LW, Li P. 2014. Direct analysis of 18 flavonol glycosides, aglycones and terpene trilactones in Ginkgo biloba tablets by matrix solid phase dispersion coupled with ultra-high performance liquid chromatography tandem triple quadrupole mass spectrometry. J Pharm Biomed Anal. 97:123–128.
  • López-Gutiérrez N, Romero-González R, Vidal JLM, Frenich AG. 2016. Quality control evaluation of nutraceutical products from Ginkgo biloba using liquid chromatography coupled to high resolution mass spectrometry. J Pharm Biomed Anal. 121:151–160.
  • Mabry TJ, Markham KR, Thomas MB. 1970. The Systematic Identification of Flavonoids. Berlin, Heidelberg: Springer.
  • Pandey R, Chandra P, Arya KR, Kumar B. 2014. Development and validation of an ultra high performance liquid chromatography electrospray ionization tandem mass spectrometry method for the simultaneous determination of selected flavonoids in Ginkgo biloba. J Sep Sci. 37(24):3610–3618.
  • von Boetticher A. 2011. Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatr Dis Treat. 7:441–447.
  • Wang F, Jiang K, Li Z. 2007. Purification and identification of genistein in Ginkgo biloba leaf extract. Chin J Chromatogr. 25(4):509–513.
  • Wohlmuth H, Savage K, Dowell A, Mouatt P. 2014. Adulteration of Ginkgo biloba products and a simple method to improve its detection. Phytomedicine. 21(6):912–918.
  • Yao JB, Du X, Jin HH, Fang L, Min H, Qiao HX, Wang RW, Kuchta K. 2017. Seasonal variability of genistein and 6-hydroxykynurenic acid contents in Ginkgo biloba leaves from different areas of China. Nat Prod Commun. 12:1241–1244.